pazufloxacin

Small moleculeexperimental

Pazufloxacin (INN) is a fluoroquinolone antibiotic. It is sold in Japan under the brand names Pasil and Pazucross. — Wikipedia

Clinical trial activity

3 trials · 4 clinical orgs · 0 marketing orgs

Phase 1
2
Phase 2
1
Phase 3
1
Phase 4
0

Earliest trial started Jul 1, 2015 (NCT02592096)

Timeline

2010s

  1. Jan 1, 2015

    Earliest Phase 1 Sponsor(trial)

  2. Jan 1, 2018

    Earliest Phase 3 Sponsor(trial)

Indications

Mechanism of action

Chemistry & pharmacology

Loading structure…

SMILES

C[C@H]1COc2c(C3(N)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23
Mol. weight
318.3 g/mol
Lipinski Ro5
Pass
Rule of 3
No
Chirality
Single Stereoisomer
Inorganic
No
Polymer
No

Oral

No

Parenteral

No

Topical

No

Sources

Also known as

  • 10-(1-aminocyclopropyl)-9-fluoro-3-methyl-7-oxo-2,3-dihydro-7h-pyrido(1,2,3-d,e)(1,4)benzoxazinecarboxylic acid
  • 7h-pyrido(1,2,3-de)-1,4-benzoxazine-6-carboxylic acid, 10-(1-aminocyclopropyl)-9-fluoro-2,3-dihydro-3-methyl-7-oxo-, (s)-
  • pazufloxacin
  • pazufloxacin
  • pazufloxacin
  • pazufloxacin
  • pazufloxacin
  • pazufloxacin
  • pazufloxacin
  • pazufloxacin mesilate
  • pazufloxacin mesilate
  • pazufloxacin mesilate
  • pazufloxacin mesilate
  • pazufloxacin mesilate
  • pazufloxacin mesylate
  • t 3761
  • t-3761

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT03696342Phase 3Oct 1, 2018Laboratorios Sophia S.A de C.V.
NCT03675841Phase 1Jul 29, 2018Lee's Pharmaceutical, Nanjing Medical University
NCT02592096Phase 1Jul 1, 2015Lee's Pharmaceutical, Qingdao Municipal Hospital
Showing 3 of 3 trials
Page 1 / 1

Organizations

Research & Development (4)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
Lee's PharmaceuticalFor profit2212015
Laboratorios Sophia S.A de C.V.For profit1112018
Nanjing Medical UniversityAcademic/Hospital1012018
Qingdao Municipal HospitalAcademic/Hospital1012015
4 organizations
Page 1 / 1